Dr. Mulualem Tadesse Jano

Academic rank: 
Email: 
m.tadesse@ur.ac.rw
Telephone: 
+250792689549
Published Papers : 

1.    Tadesse M, et al. Evaluation of infection prevention and antibiotic stewardship programs at a tertiary-care hospital in Southwest Ethiopia. Infection Prevention in Practice. 2025;7:100489.
Available online: Elsevier ScienceDirect (Infection Prevention in Practice journal)
2.    Abayneh M, et al. The prevalence of Mycobacterium tuberculosis and rifampicin resistance using GeneXpert-MTB/RIF assay in Ethiopia. BMC Pulmonary Medicine. 2025.
DOI: https://doi.org/10.1186/s12890-025-04051-8
3.    Balay G, et al. Time to sputum culture conversion among MDR-TB patients in Southwestern Oromia. BMC Pulmonary Medicine. 2025;25:518.
Available online: Springer Nature – BMC Pulmonary Medicine
4.    Massou F, et al. Multicenter field evaluation of Xpert MTB/XDR in Sub-Saharan Africa. ERJ Open Research. 2025.
DOI: https://doi.org/10.1183/23120541.00427-2025
5.    Ketema T, et al. Evaluation of extracts from used Xpert MTB/RIF cartridges. BMC Microbiology. 2025;25(1):26.
Available online: Springer Nature – BMC Microbiology
6.    Bonsa Z, et al. Treatment outcomes among MDR-TB patients in Southwestern Oromia. BMC Infectious Diseases. 2024;24:1305.
Available online: Springer Nature – BMC Infectious Diseases
7.    Balay G, et al. Resistance to pyrazinamide in M. tuberculosis isolates. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2024;43.
Available online: Elsevier ScienceDirect
8.    Bonsa Z, et al. Discordance between genotypic and phenotypic drug resistance detection. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2024;34.
Available online: Elsevier ScienceDirect
9.    Dubale M, et al. Stool-based Xpert MTB/RIF assay in children. PLoS ONE. 2022;17(5).
DOI: https://doi.org/10.1371/journal.pone.0267661
10.    Simieneh A, et al. Xpert MTB/RIF and TB-LAM for extrapulmonary TB diagnosis. PLoS ONE. 2022;17(2):e0263172.
DOI: https://doi.org/10.1371/journal.pone.0263172
11.    Admassu W, et al. Detection of TB and rifampicin resistance by Xpert MTB/RIF. PLoS ONE. 2022;17(1):e0262929.
DOI: https://doi.org/10.1371/journal.pone.0262929
12.    Tadesse M, et al. Xpert MTB/RIF for extrapulmonary TB diagnosis. Clinical Microbiology and Infection. 2019;25(8):1000–1005.
DOI: https://doi.org/10.1016/j.cmi.2018.12.018
13.    Tadesse M, et al. Predominance of Ethiopian-specific M. tuberculosis families. Infection, Genetics and Evolution. 2017;55:251–259.
DOI: https://doi.org/10.1016/j.meegid.2017.09.015
14.    Tadesse M, et al. Increased detection of smear-negative TB by GeneXpert after bleach concentration. International Journal of Mycobacteriology. 2016;5:211–218.
DOI: https://doi.org/10.1016/j.ijmyco.2016.05.004
15.    Tadesse M, et al. Drug resistance-conferring mutations in M. tuberculosis. International Journal of Mycobacteriology. 2016;5:185–191.
DOI: https://doi.org/10.1016/j.ijmyco.2016.04.002
16.    Tadesse M, et al. GeneXpert MTB/RIF for tuberculous lymphadenitis diagnosis. PLoS ONE. 2015;10(9).
DOI: https://doi.org/10.1371/journal.pone.0137471
17.    Tadesse M, et al. Concentration of lymph node aspirate improves smear microscopy. PLoS ONE. 2014;9(9).
DOI: https://doi.org/10.1371/journal.pone.0106826
18.    Abebe G, et al. Fluorescence microscopy for smear-negative TB. African Journal of Laboratory Medicine. 2020;9(1):a810.
DOI: https://doi.org/10.4102/ajlm.v9i1.810
19.    Abebe G, et al. Spoligotype-based population structure of M. tuberculosis. MicrobiologyOpen. 2018.
DOI: https://doi.org/10.1002/mbo3.740
20.    Abdissa K, et al. Bacteriological add-on tests to FNA cytology. BMC Infectious Diseases. 2014;14:720.
DOI: https://doi.org/10.1186/s12879-014-0720-8
21.    Abdissa K, et al. Diagnostic performance of LED microscopy. Tropical Medicine & International Health. 2015;20(11):1543–1548.
DOI: https://doi.org/10.1111/tmi.12563
22.    Wolde D, et al. Tuberculosis among university students. International Journal of Bacteriology. 2017.
Available online: Hindawi Publishing Corporation
23.    Shigute T, et al. MDR-TB treatment with and without surgery. Journal of Medical Diagnostic Methods. 2017;6:243.
Available online: OMICS International Journal platform
24.    Akessa GM, et al. Survival analysis of loss to follow-up among TB patients. International Journal of Statistics and Mechanics. 2015;2015:923025.
DOI: https://doi.org/10.1155/2015/923025
25.    Abayneh M, et al. Drug resistance and ESBL-producing bacteria in Ethiopia. BMC One Health Outlook. 2023;5:12.
DOI: https://doi.org/10.1186/s42522-023-00089-3
26.    Teferi A, et al. Vancomycin-resistant enterococci among cancer patients. Journal of Global Antimicrobial Resistance. 2025;41:144–150.
DOI: https://doi.org/10.1016/j.jgar.2024.12.012
27.    Gebre T, et al. Nasopharyngeal carriage of Streptococcus pneumoniae among children. Children. 2017;4:27.
DOI: https://doi.org/10.3390/children4040027
28.    Diriba K, et al. Time to recovery of diabetic patients from COVID-19. Journal of the Ethiopian Statistical Association. 2022.
Available online: ethstat.org.et
29.    Seyoum D, et al. Predicting AIDS progression using semi-Markov process. International Journal of Computational Biology and In Silico Modeling. 2016;5(2).
Available online: Journal publisher website
30.    Bedimo H, et al. Concurrent Plasmodium infection and anemia among PLHIV. Acta Tropica. 2017;169:8–13.
DOI: https://doi.org/10.1016/j.actatropica.2017.01.017
31.    Seyoum D, et al. Risk factors for mortality among HIV patients on ART. International Journal of Environmental Research and Public Health. 2017;14:296.
DOI: https://doi.org/10.3390/ijerph14030296
32.    Gizaw AT, et al. Barriers to childhood cancer diagnosis in Sub-Saharan Africa. BMC Cancer. 2025;25:1600.
Available online: Springer Nature – BMC Cancer
33.    Birlie B, et al. Mother-to-child HIV transmission predictors. Journal of AIDS & Clinical Research. 2016;7(9):605.
Available online: OMICS International Journal platform
34.    Tesfaye T, et al. Hidden burden of diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity. 2020;13:2925–2933.
DOI: https://doi.org/10.2147/DMSO.S260693
35.    Kenate S, et al. Anthropometric cut-offs for dyslipidemia diagnosis. Diabetes, Metabolic Syndrome and Obesity. 2020;13.
DOI: https://doi.org/10.2147/DMSO.S270456
36.    Berhanu S, et al. Undiagnosed hypertension in urban Ethiopia. Integrated Blood Pressure Control. 2021;14:69–76.
DOI: https://doi.org/10.2147/IBPC.S293251
37.    Zawdie B, et al. Metabolic syndrome and dietary diversity. BMC Endocrine Disorders. 2022;22:328.
DOI: https://doi.org/10.1186/s12902-022-01205-9

 

https://www.researchgate.net/profile/Mulualem-Tadesse

Brief profile: 
I am a dedicated Biomedical Scientist with over 13 years of academic and research experience, specializing in infectious diseases, with a strong focus on tuberculosis (TB), Antimicrobial Resistance (AMR), and diagnostic innovation. My expertise includes TB diagnostics, drug resistance mechanisms, whole-genome sequencing (WGS), and translational research in resource-limited settings. I currently serve as a Senior Lecturer at the University of Rwanda, where I teach undergraduate and postgraduate students and actively participate in research and community services. I am committed to advancing global health through impactful, evidence-driven research and capacity building.
Research Area: 
Biomedical Sciences, Infectious Disease, Antimicrobial resistance, Tuberculosis. Research ID (ORCID):